Fyfe Gwen A. 4
4 · ARRAY BIOPHARMA INC · Filed Oct 27, 2017
Insider Transaction Report
Form 4
Fyfe Gwen A.
Director
Transactions
- Exercise/Conversion
Common Stock
2017-10-27$10.47/sh+5,000$52,350→ 10,000 total - Award
Stock Option (Right to Buy)
2017-10-26+25,000→ 25,000 totalExercise: $10.47From: 2018-10-26Exp: 2027-10-26→ Common Stock (25,000 underlying) - Award
Restricted Stock Units
2017-10-26+5,000→ 5,000 totalExercise: $0.00From: 2018-10-26→ Common Stock (5,000 underlying) - Exercise/Conversion
Restricted Stock Units
2017-10-27−5,000→ 0 totalExercise: $0.00From: 2017-10-27→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on October 27, 2016 as a result of the vesting of all such RSUs.
- [F2]RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vest and will be settled in stock on October 26, 2018, subject to continued service on Array's board of directors.
- [F3]RSUs awarded to the reporting person on October 27, 2016 for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vested and were settled in stock on October 27, 2017.